Clinical parameters, including survival at last available follow-up, were recorded. Two radiologists independently reviewed chest CT examinations for various findings and resolved discrepancies by consensus. This retrospective study included 136 patients (75 men, 61 women mean age, 65 ± 12 years) receiving ICI therapy who underwent chest CT at 163 ED visits between 20. The purpose of our study was to evaluate chest CT findings in patients receiving ICI therapy presenting to the ED and to explore these findings' associations with clinical parameters. Patients undergoing immune checkpoint inhibitor (ICI) therapy may present to the emergency department (ED) with a wide range of immune-related adverse events. To listen to the podcast associated with this article, please select one of the following: iTunes, Google Play, or direct download.īACKGROUND. Please see the Editorial Comment by Florian J.
0 Comments
Leave a Reply. |